Jove
Visualize
Contact Us

Related Experiment Videos

The L.E.A.P.S. approach to vaccine development.

Daniel H Zimmerman1, Ken S Rosenthal

  • 1Cel-Sci Corporation, 8229 Boone Blvd, Suite 802, Vienna, VA 22182, USA. dzimmerman@cel-sci.com <dzimmerman@cel-sci.com>

Frontiers in Bioscience : a Journal and Virtual Library
|December 1, 2004
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Current status of immunological therapies for rheumatoid arthritis with a focus on antigen-specific therapeutic vaccines.

Frontiers in immunology·2024
Same author

Restoring the Balance between Pro-Inflammatory and Anti-Inflammatory Cytokines in the Treatment of Rheumatoid Arthritis: New Insights from Animal Models.

Biomedicines·2022
Same author

Vaccination by Two DerG LEAPS Conjugates Incorporating Distinct Proteoglycan (PG, Aggrecan) Epitopes Provides Therapy by Different Immune Mechanisms in a Mouse Model of Rheumatoid Arthritis.

Vaccines·2021
Same author

Why Don't We Have a Vaccine Against Autoimmune Diseases? - A Review.

Journal of clinical & cellular immunology·2019
Same author

Lessons from next generation influenza vaccines for inflammatory disease therapies.

International immunopharmacology·2019
Same author

Interactive Journal Club: Teaching an Old Dog New Tricks.

Journal of medical education and curricular development·2018
Same journal

The CD44 protein family: roles in embryogenesis and tumor progression.

Frontiers in bioscience : a journal and virtual library·2017
Same journal

Four varieties of voltage-gated proton channels.

Frontiers in bioscience : a journal and virtual library·2017
Same journal

Lurie's tubercle-count method to test TB vaccine efficacy in rabbits.

Frontiers in bioscience : a journal and virtual library·2017
Same journal

Optical spectroscopy of breast biopsies and human breast cancer xenografts in nude mice.

Frontiers in bioscience : a journal and virtual library·2017
Same journal

The colostrum-deprived, artificially-reared, neonatal pig as a model animal for studying rotavirus gastroenteritis.

Frontiers in bioscience : a journal and virtual library·2017
Same journal

Action of polypeptide growth factors in colon cancer; development of new therapeutic approaches.

Frontiers in bioscience : a journal and virtual library·2017
See all related articles
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

The Ligand Epitope Antigen Presentation System (L.E.A.P.S.) enhances vaccine immunogenicity by attaching immune peptides to epitopes. This approach customizes immune responses for effective protection against pathogens like herpes simplex virus.

Area of Science:

  • Vaccinology
  • Immunology
  • Molecular Biology

Background:

  • Epitopes may be too small to elicit an immune response.
  • Vaccine development requires strategies to enhance immunogenicity and control immune response type.
  • T cell receptor (TCR) interaction with epitopes is crucial for adaptive immunity.

Purpose of the Study:

  • To introduce the Ligand Epitope Antigen Presentation System (L.E.A.P.S.) for vaccine development.
  • To explain how L.E.A.P.S. enhances epitope immunogenicity and directs immune responses.
  • To demonstrate the customization of immune responses for disease protection.

Main Methods:

  • Covalent attachment of immune peptides (T cell binding ligand/TCBL or immune cell binding ligand/ICBL) to antigenic peptides.

Related Experiment Videos

  • Utilizing specific ICBL/TCBL peptides (J for Th1, G for Th2 responses) derived from MHC molecules.
  • Characterization of immune responses and protection from infectious challenge.

    • Main Results:

    • L.E.A.P.S. promotes epitope interaction with T cells and antigen-presenting cells.
    • Specific ICBL/TCBL peptides guide Th1 or Th2 immune responses.
    • Demonstrated efficacy in protection studies against herpes simplex virus and other pathogens.

    Conclusions:

    • The L.E.A.P.S. approach effectively enhances vaccine immunogenicity.
    • This system allows for tailored immune responses to induce protection from disease.
    • L.E.A.P.S. offers a versatile platform for developing customized vaccines.